Sitemap
November 03, 2009 Articles
Filter by Available Specialty
- Although the gold standard, many drugs approved without randomized trials
- Australian researchers retract N95 recommendation for HCWs treating patients with respiratory illness
- Australian researchers retract N95 recommendation for HCWs treating patients with respiratory illness
- Clinical recommendations for Pap test screening not consistent with screening guidelines
- Contaminated infant formula suspected in two Cronobacter infections
- Contaminated infant formula suspected in two Cronobacter infections
- FDA approved expanded indication for exenatide
- Hypofractionated radiotherapy superior to conventional in high-risk prostate cancer
- Is this a second branchial cleft cyst?
- iScience Interventional introduces micro-aspiration retinal cannula
- Low total cholesterol not a cause of cancer, high HDL may protect against some cancers
- Moria announces launch of single-use surgical instruments
- Obesity predicted adverse effects of stereotactic body radiation in patients with lung cancer
- OptiMedica launches updated photocoagulator
- Physicians should stand behind science of H1N1 vaccine
- Reduction of low-, intermediate-risk prostate cancer recurrence observed with proton therapy ‘boost’
- Shock wave therapy for long-bone nonunions comparable to surgical treatment in randomized study
- Study refutes link between central retinal artery occlusion and neovascular glaucoma